...
首页> 外文期刊>The American heart journal >Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients
【24h】

Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients

机译:具有经皮冠状动脉血运重建的临床结果与冠状动脉旁路移植手术,患者患者左右冠状动脉疾病:6例随机试验和4,686名患者的META分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment of unprotected left main coronary artery disease (ULMCAD). We therefore aimed to compare the risk of all-cause mortality between PCI and CABG in patients with ULMCAD in a pairwise meta-analysis of RCT. Methods Randomized controlled trials comparing PCI vs CABG for the treatment of ULMCAD were searched through MEDLINE, EMBASE, Cochrane databases, and proceedings of international meetings. Results Six trials including 4,686 randomized patients were identified. After a median follow-up of 39 months, there were no significant differences between PCI vs CABG in the risk of all-cause mortality (hazard ratio [HR] 0.99, 95% CI 0.76-1.30) or cardiac mortality. However, a significant interaction for cardiac mortality ( P interaction = .03) was apparent between randomization arm and SYNTAX score, such that the relative risk for mortality tended to be lower with PCI compared with CABG among patients in the lower SYNTAX score tertile, similar in the intermediate tertile, and higher in the upper SYNTAX score tertile. Percutaneous coronary intervention compared with CABG was associated with a similar long-term composite risk of death, myocardial infarction, or stroke (HR 1.06, 95% CI 0.82-1.37), with fewer events within 30 days after PCI offset by fewer events after 30 days with CABG ( P interaction .0001). Percutaneous coronary intervention was associated with greater rates of unplanned revascularization compared with CABG (HR 1.74, 95% CI 1.47-2.07). Conclusions In patients undergoing revascularization for ULMCAD, PCI was associated with similar rates of mortality compared with CABG at a median follow-up of 39 months, but with an interaction effect suggesting relatively lower mortality with PCI in patients with low SYNTAX score and relatively lower mortality with CABG in patients with high SYNTAX score. Both procedures resulted in similar long-term composite rates of death, myocardial infarction, or stroke, with PCI offering an early safety advantage and CABG demonstrating greater durability. ]]>
机译:背景技术一些但并非所有随机对照试验(RCT)表明,用药物洗脱支架经皮冠状动脉干预(PCI)可以是冠状动脉旁路接枝(CABG)手术的可接受的替代物,用于治疗未受保护的左主冠状动脉疾病( Ulmcad)。因此,我们旨在比较ULMCAD在RCT的成对荟萃分析中PCI和CABG之间的所有因果死亡率的风险。方法采用Medline,Embase,Cochrane数据库和国际会议的诉讼,搜查了比较PCI VS CABG进行ulmcad的PCI VS CABG的随机对照试验。结果确定了六项试验,包括4,686名随机患者。在39个月的中位随访后,PCI对CABG在全导致死亡率的风险中没有显着差异(危险比[HR] 0.99,95%CI 0.76-1.30)或心脏死亡率。然而,随机化臂和语法评分之间的心脏死亡率(P互动= 0.03)的显着相互作用是显而易见的,使得与PCI相比,与PCI的相对风险趋于低于患者在较低的语法得分Tertile中的CABG,类似在中间触角中,上层陈述得分Tertile。与CABG相比经皮冠状动脉介入与类似的死亡,心肌梗死或中风(HR 1.06,95%CI 0.82-1.37)相关的相关性,在30天后30天内的事件较少,较少30使用CABG的天(P交互&lt ;0001)。与CABG相比,经皮冠状动脉干预与更大的无计划血运重建速率相关(HR 1.74,95%CI 1.47-2.07)。结论患有Ulmcad血运重建的患者,与39个月的中位随访相比,PCI与CABG相比,PCI与CABG相比,但在患有低语法得分和相对较低的患者中,对PCI具有相对较低的死亡率。用CABG患者患者进行高语法得分。两种程序导致死亡,心肌梗死或中风的类似长期复合率,PCI提供早期的安全优势,CABG展现出更大的耐用性。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号